The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI

Human Molecular Genetics

Volumn 12, Issue 20, 2003, Pages 2587-2597

  Huynh, Duong P ^a,b   Scoles, Daniel R ^a,b   Nguyen, Dung ^a   Pulst, Stefan M ^a,b,c  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GENE PRODUCT; PARKIN; PROTEASOME; SYNAPTOTAGMIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BINDING AFFINITY; BRAIN REGION; CELL VACUOLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; FETUS; GENE INACTIVATION; GENE LOSS; GENE MUTATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; LEWY BODY; MISSENSE MUTATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TARGETING; REGULATORY MECHANISM; SYNAPSE VESICLE; TWO HYBRID SYSTEM;

ANIMALS; BLOTTING, WESTERN; BRAIN; CALCIUM-BINDING PROTEINS; CELL LINE; COS CELLS; GENES, RECESSIVE; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUMINESCENT PROTEINS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; MODELS, GENETIC; MUTATION; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; NEURONS; PLASMIDS; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SUBSTANTIA NIGRA; SYNAPTOTAGMINS; TIME FACTORS; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 0141995596     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg269     Document Type: Article

References (55)

1. Dunnett, S.B. and Bjorklund, A. (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature, 399, A32-39.
2. Yamada, T., McGeer, P.L., Baimbridge, K.G. and McGeer, E.G. (1990) Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res., 526, 303-307.
3. Damier, P., Hirsch, E.C., Agid, Y. and Graybiel, A.M. (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain, 122 (Pt 8), 1437-1448.
4. Naoi, M. and Maruyama, W. (1999) Cell death of dopamine neurons in aging and Parkinson's disease. Mech. Ageing Dev., 111, 175-188.
5. Le, W.D., Xu, P., Jankovic, J., Jiang, H., Appel, S.H., Smith, R.G. and Vassilatis, D.K. (2003) Mutations in NR4A2 associated with familial Parkinson disease. Nat. Genet., 33, 85-89.
6. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
7. Wintermeyer, P., Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Berg, D., Becker, G., Leroy, E., Polymeropoulos, M., Berger, K. et al. (2000) Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport, 11, 2079-2082.
8. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
9. Bonifati, V., Rizzu, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C., Squitieri, F., Ibanez, P., Joosse, M. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 299, 256-259.
10. Ishikawa, A. and Tsuji, S. (1996) Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology, 47, 160-166.
11. Ishikawa, A. and Takahashi, H. (1998) Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. J. Neurol., 245, P4-9.
12. Matsumine, H. (1998) A loss-of-function mechanism of nigral neuron death without Lewy body formation: autosomal recessive juvenile parkinsonism (AR-JP). J Neurol, 245, P10-14.
13. Abbas, N., Lucking, C.B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J.R., Gasser, T., Marconi, R. et al. (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum. Mol. Genet., 8, 567-574.
14. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. et al. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet., 25, 302-305.
15. Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N. et al. (1999) Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol., 45, 668-672.
16. Finney, N., Walther, F., Mantel, P.Y., Stauffer, D., Rovelli, G. and Dev, K.K. (2003) The cellular protein level of Parkin is regulated by its ubiquitin-like domain. J. Biol. Chem., 278, 16054-16058.
17. Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl Acad. Sci. USA, 97, 13354-13359.
18. Joazeiro, C.A. and Weissman, A.M. (2000) RING finger proteins: mediators of ubiquitin ligase activity. Cell, 102, 549-552.
19. Helliwell, S.B., Losko, S. and Kaiser, C.A. (2001) Components of a ubiquitin ligase complex specify polyubiquitination and intracellular trafficking of the general amino acid permease. J. Cell Biol., 153, 649-662.
20. Hicke, L. (2001) A new ticket for entry into budding vesicles - ubiquitin. Cell, 106, 527-530.
21. Hicke, L. (2001) Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol., 2, 195-201.
22. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell, 105, 891-902.
23. Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinsons disease. Science, 293, 263-269.
24. Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med., 7, 1144-1150.
25. Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K.I. and Takahashi, R. (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell., 10, 55-67.
26. Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron, 37, 735-749.
27. Tsai, Y.C., Fishman, P.S., Thakor, N.V. and Oyler, G.A. (2003) Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem., 278, 22044-22055.
28. Ren, Y., Zhao, J. and Feng, J. (2003) Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. J. Neurosci., 23, 3316-3324.
29. Corti, O., Hampe, C., Koutnikova, H., Darios, F., Jacquier, S., Prigent, A., Robinson, J.C., Pradier, L., Ruberg, M., Mirande, M. et al. (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum. Mol. Genet., 12, 1427-1437.
30. Fields, S. and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature, 340, 245-246.
31. Scoles, D.R., Huynh, D.P., Chen, M.S., Burke, S.P., Gutmann, D.H. and Pulst. S.M. (2000) The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate. Hum. Mol. Genet., 9, 1567-1574.
32. Engelender, S., Kaminsky, Z., Guo, X., Sharp, A.H., Amaravi, R.K., Kleiderlein, J.J., Margolis, R.L., Troncoso, J.C., Lanahan, A.A., Worley, P.F. et al. (1999) Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet., 22, 110-114.
33. Huynh, D.P., Scoles, D.R., Ho, T.H., Del Bigio, M.R. and Pulst, S.M. (2000) Parkin is associated with actin filaments in neuronal and nonneural cells. Ann. Neurol., 48, 737-744.
34. Ribeiro, C.S., Carneiro, K., Ross, C.A., Menezes, J.R. and Engelender, S. (2002) Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein. J. Biol. Chem., 277, 23927-23933.
35. Wakabayashi, K., Engelender, S., Tanaka, Y., Yoshimoto, M., Mori, F., Tsuji, S., Ross, C.A. and Takahashi, H. (2002) Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol. (Berl.), 103, 209-214.
36. Beites, C.L., Xie, H., Bowser, R. and Trimble, W.S. (1999) The septin CDCrel-1 binds syntaxin and inhibits exocytosis. Nat. Neurosci., 2, 434-439.
37. Scoles, D.R., Nguyen, V.D., Qin, Y., Sun, C.X., Morrison, H., Gutmann, D.H. and Pulst, S.M. (2002) Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling. Hum. Mol. Genet., 11, 3179-3189.
38. Fernandez-Chacon, R., Konigstorfer, A., Gerber, S.H., Garcia, J., Matos, M.F., Stevens, C.F., Brose, N., Rizo, J., Rosenmund, C. and Sudhof, T.C. (2001) Synaptotagmin I functions as a calcium regulator of release probability. Nature, 410, 41-49.
39. Geppert, M., Goda, Y., Hammer, R.E., Li, C., Rosahl, T.W., Stevens, C.F. and Sudhof, T.C. (1994) Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell, 79, 717-727.
40. von Poser, C., Ichtchenko, K., Shao, X., Rizo, J. and Sudhof, T.C. (1997) The evolutionary pressure to inactivate. A subclass of synaptotagmins with an amino acid substitution that abolishes Ca2+ binding. J. Biol. Chem., 272, 14314-14319.
41. Wang, C.T., Grishanin, R., Earles, C.A., Chang, P.Y., Martin, T.F., Chapman, E.R. and Jackson, M.B. (2001) Synaptotagmin modulation of fusion pore kinetics in regulated exocytosis of dense-core vesicles. Science, 294, 1111-1115.
42. Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C.A. and Takahashi, H. (2000) Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol., 47, 521-523.
43. Schlossmacher, M.G., Frosch, M.P., Gai, W.P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N. et al. (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am. J. Pathol., 160, 1655-1667.
44. Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S. and Takahashi, H. (2000) An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov. Disord., 15, 884-898.
45. Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Soda, K. and Mizuno, Y. (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology, 51, 890-892.
46. van de Warrenburg, B.P., Lammens, M., Lucking, C.B., Denefle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A. and Horstink, M.W. (2001) Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology, 56, 555-557.
47. Imai, Y, Soda, M. and Takahashi, R. (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem., 275, 35661-35664.
48. Fukuda, M. and Mikoshiba, K. (2001) Characterization of KIAA1427 protein as an atypical synaptotagmin (Syt XIII). Biochem. J., 354, 249-257.
49. Berton, F., Cornet, V., Iborra, C., Garrido, J., Dargent, B., Fukuda, M., Seagar, M. and Marqueze, B. (2000) Synaptotagmin I and IV define distinct populations of neuronal transport vesicles. Eur. J. Neurosci., 12, 1294-1302.
50. Ibata, K., Fukuda, M., Hamada, T., Kabayama, H. and Mikoshiba, K. (2000) Synaptotagmin IV is present at the Golgi and distal parts of neurites. J. Neurochem., 74, 518-526.
51. Fukuda, M., Ibata, K. and Mikoshiba, K. (2001) A unique spacer domain of synaptotagmin IV is essential for Golgi localization. J. Neurochem., 77, 730-740.
52. Fukuda, M., Kanno, E., Ogata, Y., Saegusa, C., Kim, T., Loh, Y.P. and Yamamoto, A. (2003) Nerve growth factor-dependent sorting of synaptotagmin IV protein to mature dense-core vesicles that undergo calcium-dependent exocytosis in PC12 cells. J. Biol. Chem., 278, 3220-3226.
53. Shibata, H., Huynh, D.P. and Pulst, S.M. (2000) A novel protein with RNA-binding motifs interacts with ataxin-2. Hum. Mol. Genet., 9, 1303-1313.
54. Scoles, D.R., Huynh, D.P., Morcos, P.A., Coulsell, E.R., Robinson, N.G., Tamanoi, F. and Pulst, S.M. (1998) Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin. Nat. Genet., 18, 354-359.
55. Poullet, P. and Tamanoi, F. (1995) Use of yeast two-hybrid system to evaluate Ras interactions with neurofibromin-GTPase-activating protein. Methods Enzymol., 255, 488-497.